Insider and congress filings
Gilead Sciences, Inc. (GILD)
About Gilead Sciences, Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Chief executive
- Daniel O'Day
- Employees
- 17,000
- Listed since
- Jan 22, 1992
- Market value
- $180.8B
- Price to earnings
- -
- Earnings per share
- -$2.61
- Dividend yield
- 2.21%
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 4, 2026 | -$6.75 | -$7.25 | $7.8B | $7.4B | EPS beatRevenue beat |
| Q1 FY2026reported May 7, 2026 | $2.03 | $1.91 | $7.0B | $6.9B | EPS beatRevenue in line |
| Feb 10, 2026 | $1.86 | $1.81 | $7.9B | $7.7B | EPS beatRevenue beat |
| Q3 FY2025reported Oct 30, 2025 | $2.47 | $2.13 | $7.8B | $7.4B | EPS beatRevenue beat |
| Q2 FY2025reported Aug 7, 2025 | $2.01 | $1.96 | $7.1B | $7.0B | EPS beatRevenue in line |
| Apr 24, 2025 | $1.81 | $1.78 | $6.7B | $6.8B | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 20, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Daniel P. O’DayChairman and Chief Executive Officer | $1.8M | $15.2M | $11.4M | $28.4M |
| Dietmar Berger, M.D., Ph.D.Chief Medical Officer | $969K | $7.0M | $6.0M | $13.9M |
| Johanna MercierChief Commercial and Corporate Affairs Officer | $1.2M | $4.6M | $3.6M | $9.3M |
| Andrew D. DickinsonChief Financial Officer | $1.1M | $4.3M | $3.3M | $8.8M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $15.4B | 121,844,108 | +2.4% | 9.80% |
| Vanguard Capital Management LLC | $10.2B | 81,091,734 | +0.5% | 6.52% |
| FMR LLC | $8.4B | 66,870,816 | -7.0% | 5.38% |
| State Street Corp | $7.7B | 61,216,552 | +2.3% | 4.92% |
| Capital World Investors | $5.2B | 40,988,975 | -0.7% | 3.30% |
| Invesco Ltd. | $5.0B | 39,819,151 | +52.8% | 3.20% |
| Vanguard Portfolio Management LLC | $4.5B | 35,316,168 | +0.5% | 2.84% |
| Geode Capital Management, LLC | $3.8B | 30,065,642 | +1.1% | 2.42% |
| Price T Rowe Associates Inc | $3.8B | 29,996,694 | +14.3% | 2.41% |
| Morgan Stanley | $3.0B | 24,004,354 | +3.0% | 1.93% |
| Dodge & Cox | $3.0B | 23,677,567 | -2.4% | 1.90% |
| Norges Bank | $2.8B | 21,965,555 | +100.0% | 1.77% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
19 filings of 318 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| Daniel Patrick O'DayChairman & CEO | Sold · scheduled · 3 lines | 15,000 | $148.64 | $2.2M | Sep 1, 2026 | 1d |
| Anthony WeltersDirector | Sold · scheduled · 4 lines | 18,000 | $148.62 | $2.7M | Aug 26, 2026 | 1d |
| Jeffrey BluestoneDirector | Sold · 5 lines | 5,000 | $145.02 | $725K | Aug 20, 2026 | 1d |
| Andrew D. DickinsonChief Financial Officer | Sold | 3,000 | $138.36 | $415K | Aug 17, 2026 | 1d |
| Johanna MercierChief Comm & Corp Aff Officer | Sold · 2 lines | 28,000 | $137.64 | $3.9M | Aug 17, 2026 | 1d |
| Daniel Patrick O'DayChairman & CEO | Sold · 3 lines | 15,000 | $130.31 | $2.0M | Aug 3, 2026 | 1d |
| Johanna MercierChief Comm & Corp Aff Officer | Sold | 3,000 | $129.92 | $390K | Jul 15, 2026 | 1d |
| Andrew D. DickinsonChief Financial Officer | Sold | 3,000 | $129.93 | $390K | Jul 15, 2026 | 1d |
| Daniel Patrick O'DayChairman & CEO | Sold · 2 lines | 15,000 | $126.29 | $1.9M | Jul 1, 2026 | 1d |
| Johanna MercierChief Comm & Corp Aff Officer | Sold · 3 lines | 3,000 | $123.92 | $372K | Jun 15, 2026 | 1d |
| Andrew D. DickinsonChief Financial Officer | Sold | 3,000 | $125.40 | $376K | Jun 15, 2026 | 1d |
| Daniel Patrick O'DayChairman & CEO | Sold · 3 lines | 15,000 | $131.46 | $2.0M | Jun 1, 2026 | 1d |
| Andrew D. DickinsonChief Financial Officer | Sold | 3,000 | $132.27 | $397K | May 15, 2026 | 3d |
| Johanna MercierChief Comm & Corp Aff Officer | Sold · 4 lines | 28,000 | $131.29 | $3.7M | May 15, 2026 | 3d |
| Daniel Patrick O'DayChairman & CEO | Sold · 2 lines | 10,000 | $129.16 | $1.3M | Apr 28, 2026 | 1d |
| Johanna MercierChief Comm & Corp Aff Officer | Sold | 3,000 | $140.96 | $423K | Apr 15, 2026 | 1d |
| Andrew D. DickinsonChief Financial Officer | Sold | 3,000 | $140.96 | $423K | Apr 15, 2026 | 1d |
| Daniel Patrick O'DayChairman & CEO | Sold | 10,000 | $136.82 | $1.4M | Mar 27, 2026 | 3d |
| Johanna MercierChief Comm & Corp Aff Officer | Sold | 3,000 | $144.23 | $433K | Mar 16, 2026 | 1d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in GILD
20 disclosures of 112 on record · median 28d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +9.5%S&P -1.4% · vs S&P 500 +10.8% | Aug 10, 2026 | Sep 4, 2026 | 25d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +6.8%S&P +2.0% · vs S&P 500 +4.8% | Jul 7, 2026 | Aug 7, 2026 | 31d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +9.3%S&P +2.7% · vs S&P 500 +6.6% | Jul 20, 2026 | Aug 7, 2026 | 18d |
| Alan ArmstrongSelfFiled late | Stock | Purchase | $1,001 - $15,000 | +8.5%S&P +20.2% · vs S&P 500 -11.7% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +14.5%S&P +1.6% · vs S&P 500 +12.9% | Jun 16, 2026 | Jul 6, 2026 | 20d |
| Jared MoskowitzDependent child | Stock | Purchase | $1,001 - $15,000 | +6.9%S&P +3.9% · vs S&P 500 +3.0% | May 6, 2026 | Jun 19, 2026 | 44d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +12.4%S&P +3.2% · vs S&P 500 +9.3% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +4.8%S&P +11.1% · vs S&P 500 -6.4% | Apr 13, 2026 | May 11, 2026 | 28d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +3.3%S&P +9.6% · vs S&P 500 -6.2% | Jan 27, 2026 | Feb 26, 2026 | 30d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +4.4%S&P +9.8% · vs S&P 500 -5.4% | Jan 29, 2026 | Feb 6, 2026 | 8d |
| Val T. HoyleSpouse | Stock | Sale | $1,001 - $15,000 | +27.3%S&P +14.6% · vs S&P 500 +12.7% | Sep 23, 2025 | Oct 10, 2025 | 17d |
| Val T. HoyleSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +65.4%S&P +31.1% · vs S&P 500 +34.3% | Oct 29, 2024 | Sep 12, 2025 | 318d |
| Jefferson Shreve | Stock | Sale | $15,001 - $50,000 | +40.8%S&P +31.7% · vs S&P 500 +9.2% | May 12, 2025 | Jun 22, 2025 | 41d |
| Marjorie Taylor Greene | Stock | Purchase | $1,001 - $15,000 | +29.5%S&P +27.3% · vs S&P 500 +2.2% | Jun 6, 2025 | Jun 18, 2025 | 12d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +48.1%S&P +29.8% · vs S&P 500 +18.3% | May 14, 2025 | Jun 11, 2025 | 28d |
| John BoozmanJoint | Stock | Sale (Full) | $1,001 - $15,000 | +38.9%S&P +45.0% · vs S&P 500 -6.2% | Apr 16, 2025 | May 14, 2025 | 28d |
| Marjorie Taylor Greene | Stock | Purchase | $1,001 - $15,000 | +41.7%S&P +35.3% · vs S&P 500 +6.4% | May 5, 2025 | May 6, 2025 | 1d |
| Carol D. Miller | Stock | Purchase | $1,001 - $15,000 | +24.3%S&P +36.0% · vs S&P 500 -11.7% | Mar 10, 2025 | Apr 11, 2025 | 32d |
| Jefferson Shreve | Stock | Purchase | $15,001 - $50,000 | +30.0%S&P +36.4% · vs S&P 500 -6.4% | Mar 31, 2025 | Apr 11, 2025 | 11d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +24.1%S&P +32.4% · vs S&P 500 -8.3% | Mar 7, 2025 | Apr 10, 2025 | 34d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
15 members · estimate, as of Sep 10, 202615 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| J. French Hill | Republican · House | $50,001 - $100,000 | 0.5% |
| Jacky Rosen | Democrat · Senate | $50,001 - $100,000 | 0.8% |
| Marjorie Taylor Greene | Republican · House | $15,001 - $50,000 | 1.0% |
| Deborah K. Ross | Democrat · House | $15,001 - $50,000 | 2.8% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.3% |
| Jared Moskowitz | Democrat · House | $15,001 - $50,000 | 0.4% |
| Angus S. King Jr. | Independent · Senate | $1,001 - $15,000 | 0.3% |
| Rand Paul | Republican · Senate | $1,001 - $15,000 | 57.7% |
| Shelley Moore Capito | Republican · Senate | $1,001 - $15,000 | 0.5% |
| Carol D. Miller | Republican · House | $1,001 - $15,000 | 0.4% |
| Julie Johnson | Democrat · House | $1,001 - $15,000 | 0.1% |
| Robert B. Aderholt | Republican · House | $1,001 - $15,000 | 1.2% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
| John Boozman | Republican · Senate | $1,001 - $15,000 | 0.1% |
A further 1 member reports a position estimated under $1,000; those are not listed.
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Anthony WeltersDirector | Option exercise | 18,000 | Aug 26, 2026 |
| Jeffrey BluestoneDirector | Option exercise | 9,665 | Aug 20, 2026 |
| Johanna MercierChief Comm & Corp Aff Officer | Option exercise | 25,000 | Aug 17, 2026 |
| Keeley M. Cain WettanEVP Gen Counsel, Legal & Comp | Option exercise | 6,002 | Aug 10, 2026 |
| Keeley M. Cain WettanEVP Gen Counsel, Legal & Comp | Tax withholding | 2,908 | Aug 10, 2026 |
| Johanna MercierChief Comm & Corp Aff Officer | Tax withholding | 1,341 | Jun 10, 2026 |
| Keeley M. Cain WettanEVP Gen Counsel, Legal & Comp | Tax withholding | 283 | Jun 10, 2026 |
| Johanna MercierChief Comm & Corp Aff Officer | Option exercise | 2,796 | Jun 10, 2026 |
| Andrew D. DickinsonChief Financial Officer | Option exercise | 2,796 | Jun 10, 2026 |
| Dietmar BergerChief Medical Officer | Option exercise | 533 | Jun 10, 2026 |
| Keeley M. Cain WettanEVP Gen Counsel, Legal & Comp | Option exercise | 589 | Jun 10, 2026 |
| Daniel Patrick O'DayChairman & CEO | Tax withholding | 4,213 | Jun 10, 2026 |
| Daniel Patrick O'DayChairman & CEO | Option exercise | 8,779 | Jun 10, 2026 |
| Andrew D. DickinsonChief Financial Officer | Tax withholding | 1,341 | Jun 10, 2026 |
| Dietmar BergerChief Medical Officer | Tax withholding | 263 | Jun 10, 2026 |
| Johanna MercierChief Comm & Corp Aff Officer | Option exercise | 25,000 | May 15, 2026 |
| Jeffrey BluestoneDirector | Stock award | 6,030 | Apr 30, 2026 |
| Kelly A. KramerDirector | Stock award | 6,030 | Apr 30, 2026 |
| Harish ManwaniDirector | Stock award | 6,030 | Apr 30, 2026 |
| Harish ManwaniDirector | Tax withholding | 224 | Apr 30, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling GILD?
Across the 19 most recent open-market filings shown here, 0 were purchases and 19 were sales. 2 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded GILD?
Ro Khanna, Alan Armstrong, Jared Moskowitz, Josh Gottheimer, Val T. Hoyle, Jefferson Shreve and others disclosed GILD transactions in the filings shown here.
Which members of Congress hold GILD?
15 members of Congress report a position in GILD in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to J. French Hill, Jacky Rosen and Marjorie Taylor Greene. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is GILD in the S&P 500 or the Nasdaq 100?
Gilead Sciences, Inc. is a current member of the S&P 500 and Nasdaq 100, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are GILD trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 28 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.